{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:30:16Z","timestamp":1790314216286,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jgar.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:45:54Z","timestamp":1776177954000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Chloroquine resistance transporter drives divergent multi-locus drug resistance genetic backgrounds and susceptibility in Gambian Plasmodium falciparum"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9395-7492","authenticated-orcid":false,"given":"Ndey Fatou","family":"Drammeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatoumata","family":"Bojang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-8404","authenticated-orcid":false,"given":"Nora Nghochuzie","family":"Nganyewo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7029-5305","authenticated-orcid":false,"given":"Aminata Seedy","family":"Jawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baboucarr","family":"Manneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3999-7852","authenticated-orcid":false,"given":"Brandon Nji","family":"Amambua-Ngwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8402-9182","authenticated-orcid":false,"given":"Haddijatou","family":"Mbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7911-6457","authenticated-orcid":false,"given":"Eniyou Cheryll","family":"Oriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1592-6407","authenticated-orcid":false,"given":"Colin J.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"D'Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4478-3601","authenticated-orcid":false,"given":"Alfred","family":"Amambua-Ngwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.04.003_bib0001","unstructured":"World Health Organisation. World malaria report 2015 - summary 2015,https:\/\/www.who.int\/publications\/i\/item\/WHO-HTM-GMP-2016.2; 2015 [accessed 15.05.25]."},{"key":"10.1016\/j.jgar.2026.04.003_bib0002","unstructured":"World Health Organization. World malaria report 2024, https:\/\/www.who.int\/publications\/i\/item\/9789240104440; 2024 [accessed 8.04. 26]."},{"key":"10.1016\/j.jgar.2026.04.003_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00720-20","article-title":"Tolerance of Gambian plasmodium falciparum to dihydroartemisinin and lumefantrine detected by ex vivo parasite survival rate assay","volume":"65","author":"Mbye","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.003_bib0004","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14787210.2021.1962291","article-title":"Current and emerging strategies to combat antimalarial resistance","volume":"20","author":"Rasmussen","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2026.04.003_bib0005","series-title":"Encyclopedia of Malaria","first-page":"1","article-title":"Pharmacology of antimalarial drugs, current anti-malarials","author":"Na-Bangchang","year":"2019"},{"key":"10.1016\/j.jgar.2026.04.003_bib0006","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2026.04.003_bib0007","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMe2110659","article-title":"Emergence of artemisinin-resistant plasmodium falciparum in East Africa","volume":"385","author":"White Nicholas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2026.04.003_bib0008","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s40471-021-00266-5","article-title":"Antimalarial drug resistance and implications for the WHO Global Technical Strategy","volume":"8","author":"Ippolito","year":"2021","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.jgar.2026.04.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01542-19","article-title":"Modification of pfap2\u00b5 and pfubp1 markedly reduces ring-stage susceptibility of Plasmodium falciparum to artemisinin in vitro","volume":"64","author":"Henrici","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.003_bib0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12936-020-03358-7","article-title":"Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya","volume":"19","author":"Chebore","year":"2020","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2026.04.003_bib0011","article-title":"Genomic epidemiology of artemisinin resistant malaria","volume":"5","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.jgar.2026.04.003_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00085-9","article-title":"Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study","volume":"2","author":"Tumwebaze","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jgar.2026.04.003_bib0013","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","article-title":"Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia","volume":"8","author":"Fola","year":"2023","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jgar.2026.04.003_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-36002-w","article-title":"Genome-wide genetic variation and molecular surveillance of drug resistance in Plasmodium falciparum isolates from asymptomatic individuals in Ou\u00e9less\u00e9bougou, Mali","volume":"13","author":"Vanheer","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2026.04.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00016-8","article-title":"The 2023 WHO World malaria report","volume":"5","author":"Venkatesan","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jgar.2026.04.003_bib0016","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.4269\/ajtmh.16-0053","article-title":"West Africa International Centers of Excellence for Malaria Research: drug resistance patterns to Artemether\u2013Lumefantrine in Senegal, Mali, and the Gambia","volume":"95","author":"Dieye","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2026.04.003_bib0017","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/s41564-023-01377-z","article-title":"Chloroquine resistance evolution in Plasmodium falciparum is mediated by the putative amino acid transporter AAT1","volume":"8","author":"Amambua-Ngwa","year":"2023","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jgar.2026.04.003_bib0018","first-page":"1","article-title":"Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012\u20132022","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2026.04.003_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001788","article-title":"Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets","volume":"12","author":"Hofmann","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jgar.2026.04.003_bib0020","unstructured":"Paragon Genomics. CleanPlex amplicon sequencing for targeted DNA and RNA seq., https:\/\/www.paragongenomics.com\/targeted-sequencing\/amplicon-sequencing\/cleanplex-ngs-amplicon-sequencing\/; 2024 [accessed 10.06.24]."},{"key":"10.1016\/j.jgar.2026.04.003_bib0021","unstructured":"EPPIcenter\/mad4hatter. Pipeline to process Plasmodium amplicon sequencing data, https:\/\/github.com\/EPPIcentre\/mad4hatter; 2024 [accessed 16.12.2024]."},{"key":"10.1016\/j.jgar.2026.04.003_bib0022","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/molbev\/msz312","article-title":"Molecular evolutionary genetics analysis (MEGA) for macOS","volume":"37","author":"Stecher","year":"2020","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.jgar.2026.04.003_bib0023","doi-asserted-by":"crossref","first-page":"W78","DOI":"10.1093\/nar\/gkae268","article-title":"Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool","volume":"52","author":"Letunic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jgar.2026.04.003_bib0024","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.003_bib0025","unstructured":"Infectious Diseases Data Observatory. WWARN\u2019s in vitro analysis and reporting tool (IVART). https:\/\/www.iddo.org\/wwarn\/ivart; 2025 [accessed 8.04.26]."},{"key":"10.1016\/j.jgar.2026.04.003_bib0026","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1128\/AAC.02350-12","article-title":"High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial resistance Network (WWARN) in vitro analysis and reporting tool","volume":"57","author":"Woodrow","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.003_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00759-17","article-title":"Sustained ex vivo susceptibility of Plasmodium falciparum to artemisinin derivatives but increasing tolerance to artemisinin combination therapy partner quinolines in the Gambia","volume":"61","author":"Amambua-Ngwa","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.003_bib0028","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/jac\/dkaf129","article-title":"Plasmodium falciparum isolates: ex vivo drug response","volume":"80","author":"Adika","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.04.003_bib0029","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1475-2875-10-268","article-title":"Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia","volume":"10","author":"Pradines","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2026.04.003_bib0030","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1475-2875-12-450","article-title":"A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs","volume":"12","author":"Quashie","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2026.04.003_bib0031","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1128\/JCM.37.3.700-705.1999","article-title":"In vitro culture and drug sensitivity assay of Plasmodium falciparum with nonserum substitute and acute-phase sera","volume":"37","author":"Ringwald","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2026.04.003_bib0032","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12936-019-2716-z","article-title":"Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors","volume":"18","author":"Ocan","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2026.04.003_bib0033","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/s41564-023-01516-6","article-title":"Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana","volume":"8","author":"Girgis","year":"2023","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jgar.2026.04.003_bib0034","article-title":"Additional PfCRT mutations driven by selective pressure for improved fitness can result in the loss of piperaquine resistance and altered Plasmodium falciparum physiology","volume":"15","author":"Hagenah","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.jgar.2026.04.003_bib0035","doi-asserted-by":"crossref","unstructured":"Fola AA, Kobayashi T, Shields T, Hamapumbu H, Musonda M, Katowa B, et al. Temporal genomic analysis of Plasmodium falciparum reveals increased prevalence of mutations associated with delayed clearance following treatment with artemisinin-lumefantrine in Choma District, Southern Province, Zambia [preprint]. medRxiv 2024. https:\/\/doi.org\/10.1101\/2024.06.05.24308497.","DOI":"10.1101\/2024.06.05.24308497"},{"key":"10.1016\/j.jgar.2026.04.003_bib0036","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012476","article-title":"Hydroxychloroquine in rheumatic autoimmune disorders and beyond","volume":"12","author":"Nirk","year":"2020","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jgar.2026.04.003_bib0037","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12936-020-03506-z","article-title":"Plasmodium falciparum multidrug resistance gene-1 polymorphisms in Northern Nigeria: implications for the continued use of artemether-lumefantrine in the region","volume":"19","author":"Adamu","year":"2020","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2026.04.003_bib0038","doi-asserted-by":"crossref","unstructured":"Rosado J, Fola AA, Cojean S, Sarrasin V, Copp\u00e9e R, Zaffaroulah R, et al. Ex vivo susceptibility to antimalarial drugs and polymorphisms in drug resistance genes of African Plasmodium falciparum, 2016-2023: a genotype-phenotype association study 2024 [preprint]. medRxiv 2024. https:\/\/doi.org\/10.1101\/2024.07.17.24310448.","DOI":"10.1101\/2024.07.17.24310448"},{"key":"10.1016\/j.jgar.2026.04.003_bib0039","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12879-019-3921-7","article-title":"Analysis of Plasmodium falciparum Na+\/H+ exchanger (pfnhe1) polymorphisms among imported African malaria parasites isolated in Wuhan, Central China","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2026.04.003_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298585","article-title":"Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: implication of policy change and implementation of more effective drugs in fight against malaria","volume":"19","author":"Okore","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2026.04.003_bib0041","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jgar.2026.04.003_bib0042","doi-asserted-by":"crossref","unstructured":"Balmer AJ, White NFD, \u00dcnl\u00fc ES, Lee C, Pearson RD, Almagro-Garcia J, et al. Understanding the global rise of artemisinin resistance: insights from over 100,000 Plasmodium falciparum samples. Elife 2025;14:e105544. https:\/\/doi.org\/10.1101\/2024.08.23.609367.","DOI":"10.7554\/eLife.105544"},{"key":"10.1016\/j.jgar.2026.04.003_bib0043","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpddr.2019.04.002","article-title":"In vitro susceptibility of Plasmodium falciparum isolates from the China-Myanmar border area to artemisinins and correlation with K13 mutations","volume":"10","author":"Zhang","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.jgar.2026.04.003_bib0044","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jgar.2026.04.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00873-21","article-title":"Persistent submicroscopic Plasmodium falciparum parasitemia 72 hours after treatment with artemether-lumefantrine predicts 42-day treatment failure in Mali and Burkina Faso","volume":"65","author":"Beshir","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.003_bib0046","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1186\/s12879-023-08812-w","article-title":"Distribution of Plasmodium falciparum K13 gene polymorphisms across transmission settings in Ghana","volume":"23","author":"Dieng","year":"2023","journal-title":"BMC Infect Dis"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:30:29Z","timestamp":1781767829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716526000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"alternative-id":["S2213716526000536"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.04.003","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chloroquine resistance transporter drives divergent multi-locus drug resistance genetic backgrounds and susceptibility in Gambian Plasmodium falciparum","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}